DRIVER REHABILITATION

792 College Pkwy STE102, Colchester, Vermont, United States

Also known as:

university of vermont medical center

Clinical Trials

9 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

55.8%

Phase 2

25.6%

Phase 4

4.7%

Phase 1

2.3%

Trial Status Distribution

Completed

34.9%

Enrolling By Invitation

7.0%

Not yet recruiting

13.9%

Recruiting

23.3%

Terminated

7.0%

Unknown

13.9%

Clinical Trials

Trials sponsored by this organization (43)

Shortening Radiation Course Duration Using Simultaneous Integrated Boost With Lower Intensity Elective Nodal Dosing and Concurrent Chemotherapy for High-Risk Anal Squamous Cell Carcinoma

Phase 2

Enrolling By Invitation

interventional

Aug 202624 participants

Feasibility and Expansion Trial of Transcutaneous Vagus Nerve Stimulation (tVNS) for Immune-Related Fatigue in Patients Receiving Immune Checkpoint Inhibitors

Not Applicable

Not yet recruiting

interventional

Jul 202613 participants

Nutritional Prehabilitation to Improve Cancer Outcomes (N-PICO)

Not Applicable

Recruiting

interventional

Sep 2025240 participants

Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial

Phase 2

Recruiting

interventional

Jun 202545 participants

MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer

Phase 2

Recruiting

interventional

Jun 202524 participants

Page 1 of 6

Approvals

No approval data available

News

No news articles found

Back to Organizations

DRIVER REHABILITATION

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (43)

Gardening for Health for Cancer Survivors

MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma

Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer

Shortening Radiation Course Duration Using Simultaneous Integrated Boost With Lower Intensity Elective Nodal Dosing and Concurrent Chemotherapy for High-Risk Anal Squamous Cell Carcinoma

Feasibility and Expansion Trial of Transcutaneous Vagus Nerve Stimulation (tVNS) for Immune-Related Fatigue in Patients Receiving Immune Checkpoint Inhibitors

Nutritional Prehabilitation to Improve Cancer Outcomes (N-PICO)

Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial

MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer

Approvals

News